Safety and efficacy of clomiphene citrate and L-carnitine in idiopathic male infertility: A comparative study

Fertility-Infertility Research Center, Urology and Nephrology Research Center, Imam Reza Hospital, Kermanshah University of Medical Sciences, Kermanshah, Iran.
Urology journal (Impact Factor: 0.57). 06/2010; 7(3):188-93.
Source: PubMed


To compare the effects of L-carnitine with clomiphene citrate in idiopathic infertile men.
Fifty-two men with idiopathic infertility were recruited in this randomized controlled trial. They were randomly assigned into 2 treatment groups, group 1 (n = 20) and group 2 (n = 32), who received L-carnitine 25 mg/day and clomiphene citrate 2 gr/day, respectively, for a period of 3 months.
Comparing the effect of L-carnitine and clomiphene on sperm parameters before and after the treatment, both medications had influence on sperm count and motility (P = .01). L-carnitine significantly increased the semen volume (P = .001), while clomiphene citrate was significantly associated with the motility percentage and normal morphology (P = .008).
It seems that the use of clomiphene citrate and L-carnitine, either individually or in combination, as the first step of idiopathic male infertility treatment is reasonable, safe, and effective.

Download full-text


Available from: Alireza Ahmadi,
  • Source
    • "However, this recommendation was absent in the most recently published EAU guidelines [64]. Other small randomized trials using combinations of hormonal therapy and antioxidants (anti-estrogen, clomiphene with an antioxidant, L-carnitine or vitamin E) have shown a beneficial effect on sperm parameters and pregnancy rates [65,66]. In addition, other studies with various combinations of antioxidants have been performed. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Male factors account for 20%-50% of cases of infertility and in 25% of cases, the etiology of male infertility is unknown. Effective treatments are well-established for hypogonadotropic hypogonadism, male accessory gland infection, retrograde ejaculation, and positive antisperm antibody. However, the appropriate treatment for idiopathic male infertility is unclear. Empirical medical treatment (EMT) has been used in men with idiopathic infertility and can be divided into two categories based on the mode of action: hormonal treatment and antioxidant supplementation. Hormonal medications consist of gonadotropins, androgens, estrogen receptor blockers, and aromatase inhibitors. Antioxidants such as vitamins, zinc, and carnitines have also been widely used to reduce oxidative stress-induced spermatozoa damage. Although scientifically acceptable evidence of EMT is limited because of the lack of large, randomized, controlled studies, recent systematic reviews with meta-analyses have shown that the administration of gonadotropins, anti-estrogens, and oral antioxidants results in a significant increase in the live birth rate compared with control treatments. Therefore, all physicians who treat infertility should bear in mind that EMT can improve semen parameters and subsequent fertility potential through natural intercourse.
    Clinical and Experimental Reproductive Medicine 09/2014; 41(3):108-14. DOI:10.5653/cerm.2014.41.3.108
  • Source
    • "Although males affected by azoospermia, a condition resulting in a complete lack of spermatozoa in semen, have virtually no chance of conceiving spontaneously, those affected by teratospermia , asthenospermia, and oligozoospermia could have reduced chances for conception. At present, few treatments are potentially effective for male factor infertility, including medications such as clomiphene citrate (Moradi et al, 2010) and aromatase inhibitors (Raman and Schlegel, 2002) or operative therapy such as varicocoelectomy. More recently, coenzyme Q10, a mitochondrial nutrient, has been shown to improve sperm motility. "
    [Show abstract] [Hide abstract]
    ABSTRACT: The objective of this study was to determine the effects of low-level laser light exposure on the motility of spermatozoa and on DNA damage. Thirty-three semen samples were collected for routine analysis and were classified as normospermic, oligospermic, or asthenospermic. After routine semen analysis was performed, residual semen was divided into treated and control aliquots. Treated samples were exposed to a 30-second infrared laser pulse of 50 mW/cm(2) at 905 nm, a wavelength thought to increase light-sensitive cytochrome c oxidase in the mitochondrial electron transport chain. Samples were then incubated at 37°C, and aliquots were analyzed at 30 minutes and 2 hours using computerassisted semen analysis. After incubation, 250 μL of each sample was frozen at 280°C until DNA fragmentation analysis by flow cytometry. A significant increase in motility, most prominent in oligospermic and asthenospermic samples (85% increase), was observed 30 minutes after the treatment (P < .0001). No significant increase in DNA damage compared with control samples was observed. Significant changes in sperm motion kinetics were observed. Low-level laser light exposure appears to have a positive short-term effect on the motility of treated spermatozoa and did not cause any increase in DNA damage measured at 2 hours. We conclude that some cases of asthenospermia may be related to mitochondrial dysfunction. The implications of this study in terms of future clinical applications needs further investigation.
    Journal of Andrology 07/2011; 33(3):469-73. DOI:10.2164/jandrol.111.013458 · 2.47 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: To test the hypothesis that the free L-camitine helps in maintaining normal fertility. The present descriptive study was designed to show comparison of seminal free L-carnitine and sperm quality. Case controlled convenient sampling was used to assess infertile male subjects from fertile. A total of 61 adult males were selected by consent, and were categorized as fertile and infertile on the basis of history and semen analysis. Subjects were selected from Infertility Clinic, Reproductive Health Services Centre of Jinnah Postgraduate Medical Centre, Karachi. Subject's with history of pelvic surgery, or suffering from diabetes mellitus, thyroid diseases or using steroids, antihypertensives and antipsychotics drugs were excluded from the study. Groups were compared using student's t-test and p < 0.05 was considered as statistically significant. The mean values of sperm count, total motility and normal morphology of asthenospermic and oligoasthenoteratospermic were found significantly (p < 0.05) lower when compared with fertile (control). When levels of seminal free L-carnitine were compared among groups, the result showed that infertile subjects had significantly lower (P < 0.001) when compared to fertile subjects with lowest concentration in azoospermic group. The results of this study suggested that L-carnitine level in seminal plasma plays an essentialrole in maintaining male fertility. However larger studies on Pakistani population with this approach are warranted.
    Journal of the Pakistan Medical Association 08/2011; 61(8):732-6. · 0.41 Impact Factor
Show more